The Food and Drug Administration has approved GlaxoSmithKline's Mekinist (trametinib) for use in combination with Tafinlar (dabrafenib) as a possible treatment for patients suffering from inoperable melanoma and certain types of metastatic melanoma. » More
Valeant Pharmaceuticals has partnered with a beauty company to create aesthetic products, beginning with a technology that reshapes the appearance of the skin. » More
Share »
fyi...
76%
Percentage of physicians who have completed an ICD-10 impact assessment
Like
Tweet
